Adding to these findings, we now demonstrate that PD-L1 has to be glycosylated at each of its N-linked glycosylation sites (N35, N192, N200 and N219; [25,26,27]) in order to exert cell-autonomous tumor-promoting functions in breast tumor cells in vitro. Here, CD274 is linked to breast neoplasm.